Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Sunitinib in metastatic renal cell carcinoma: Experience from single center study, efficacy and safety.

Patel KB, Panchal HP, Karanwal AB, Parekh BB, Shah S, Prasad S.

Indian J Cancer. 2016 Jan-Mar;53(1):118-22. doi: 10.4103/0019-509X.180844.

2.

Safety and Efficacy of Eltrombopag in Post-hematopoietic Stem Cell Transplantation (HSCT) Thrombocytopenia.

Raut SS, Shah SA, Sharanangat VV, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Shukla SN.

Indian J Hematol Blood Transfus. 2015 Dec;31(4):413-5. doi: 10.1007/s12288-014-0491-0. Epub 2014 Dec 27.

3.

Unrelated Umbilical Cord Blood Transplant for Children with β-Thalassemia Major.

Shah SA, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Parekh BB, Shukla SN, Raut SS.

Indian J Hematol Blood Transfus. 2015 Mar;31(1):9-13. doi: 10.1007/s12288-014-0391-3. Epub 2014 Jun 19.

4.

Improving Outcome of Aplastic Anaemia with HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantation: An Experience of Gujarat Cancer and Research Institute (GCRI).

Raut SS, Shah SA, Patel KA, Shah KM, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Parekh BB, Shukla SN.

Indian J Hematol Blood Transfus. 2015 Mar;31(1):1-8. doi: 10.1007/s12288-014-0397-x. Epub 2014 May 8.

5.

Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.

Karanwal AB, Parikh BJ, Goswami P, Panchal HP, Parekh BB, Patel KB.

Indian J Med Paediatr Oncol. 2013 Apr;34(2):85-8. doi: 10.4103/0971-5851.116184.

6.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group..

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

Supplemental Content

Loading ...
Support Center